[1]
O. Dasser, O. F. benaceur, S. Fadel, and R. Kaanane, “Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors”, MEDIN, Sep. 2026, doi: 10.47852/bonviewMEDIN62029449.